GILD GILEAD SCIENCES INC Company Mergers 8-K Filing 2024 - Acquisition of CymaBay Therapeutics Gilead Sciences, Inc. completed the acquisition of CymaBay Therapeutics, Inc. for approximately $4.3 billion.Get access to all SEC 8-K filings of the GILEAD SCIENCES INC